Welcome
Support Centre
12 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Is melatonin a natural sleep promoter and antidepressant?
Source of recordUK Trials
ISRCTNISRCTN82912246
Date ISRCTN assigned19/12/2002
Local reference number(s)00/05A
Public titleIs melatonin a natural sleep promoter and antidepressant?
Scientific title
AcronymN/A
Disease/condition/study domainNeurosciences, psychiatry
Study hypothesisThe purpose and objectives of the research are to determine whether exogenous melatonin will normalise the sleep-wake cycle in depression and improve mood in depression.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Age 18 - 65
2. Diagnostic and Statistical Manual of Mental Disorders, Fourth edition (DSM-IV) diagnosis of major depression (unipolar)
3. Scoring 71 on Beck Depression Inventory (BDI)
4. Waking 2 or more hours than usual
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date05/02/2001
Anticipated end date31/10/2003
Status of trialCompleted
Target number of participants72 (36 in each group)
InterventionsConventional Rx and either melatonin 5 mg nocte or placebo.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingThe Sir Jules Thorn Charitable Trust (UK)
Sponsor nameThe Sir Jules Thorn Charitable Trust (UK)
Sponsor details24 Manchester Square
London
United Kingdom
W1U 3TH
Sponsor telephone+44 (0)20 7487 5851
Sponsor fax+44 (0)20 7224 3976
Sponsor emailjulesthorntrust@compuserve.com
Sponsor websitehttp://www.julesthorntrust.org.uk/
Contact nameDr Peter Raven
Contact detailsRoyal Free and University College Medical School
Department of Psychiatry and Behavioural Sciences
Royal Free Campus
Rowland Hill Street
London
United Kingdom
NW3 2PF
Contact telephone+44 (0)20 7794 0500
Contact fax+44 (0)20 7830 2808
Contact emailraven@rfhsm.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN82912246
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central